The United States Patent and Trademark Office has approved a patent from Israel’s Oramed for its invention, titled “Methods and Compositions for Oral Administrations of Proteins.” The patent is the basis for Oramed’s ORMD-0801 oral insulin for the early treatment of types 1 and 2 diabetes.
http://biotuesdays.com/2015/09/24/oramed-gets-patent-for-oral-administration-of-proteins/